| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Waldencast plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.35 |
| 52 Week High | US$12.00 |
| 52 Week Low | US$3.27 |
| Beta | 0 |
| 11 Month Change | -21.36% |
| 3 Month Change | -51.17% |
| 1 Year Change | -55.51% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.55% |
Recent News & Updates
Waldencast Plc: Investors Continue To Demand More Growth
Jun 28We Think Waldencast (NASDAQ:WALD) Has A Fair Chunk Of Debt
Jun 19
Recent updates
Waldencast Plc: Investors Continue To Demand More Growth
Jun 28We Think Waldencast (NASDAQ:WALD) Has A Fair Chunk Of Debt
Jun 19Waldencast plc (NASDAQ:WALD) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
May 11Waldencast plc's (NASDAQ:WALD) Intrinsic Value Is Potentially 55% Above Its Share Price
Apr 07Is Waldencast plc (NASDAQ:WALD) Trading At A 42% Discount?
Dec 14Waldencast Acquisition reports Q2 results; reaffirms FY22 guidance
Aug 11Shareholder Returns
| WALD | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -17.1% | -3.8% | 0.5% |
| 1Y | -55.5% | -30.3% | 20.5% |
Return vs Industry: WALD underperformed the US Personal Products industry which returned -29.3% over the past year.
Return vs Market: WALD underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| WALD volatility | |
|---|---|
| WALD Average Weekly Movement | 8.4% |
| Personal Products Industry Average Movement | 8.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: WALD's share price has been volatile over the past 3 months.
Volatility Over Time: WALD's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 284 | Michel Brousset | www.waldencast.com |
Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Waldencast plc Fundamentals Summary
| WALD fundamental statistics | |
|---|---|
| Market cap | US$438.66m |
| Earnings (TTM) | -US$89.98m |
| Revenue (TTM) | US$218.14m |
1.9x
P/S Ratio-4.5x
P/E RatioIs WALD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WALD income statement (TTM) | |
|---|---|
| Revenue | US$218.14m |
| Cost of Revenue | US$76.56m |
| Gross Profit | US$141.58m |
| Other Expenses | US$231.56m |
| Earnings | -US$89.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | -0.74 |
| Gross Margin | 64.90% |
| Net Profit Margin | -41.25% |
| Debt/Equity Ratio | 20.8% |
How did WALD perform over the long term?
See historical performance and comparison